Correct on both counts. P results will be a classic

New Post Public Reply Private Reply Replies (0) Message Board
ericseb2003 takingabath #18757
Correct on both counts.

P results will be a classic biotech binary event. The drug worked amazingly in animal studies, and if that holds true in this recent human trial, it will change the fortunes of CTIX dramatically, but it could also end up being a complete dud that will leave a mark in the short-term. I do think (for various reasons) that the upside reward for our share price stemming from successful results would be multiples bigger than the downside risk if there is a failure. So 50/50 chance it works or it doesn't, but good results would have a disproportionately bigger impact than bad results, imo.

And ASCO is not a guarantee. We've presented there multiple years in a row, and with funding needs still out there, I'd think we'd like to leverage such an opportunity to market our lead cancer drug, and have to believe Leo and crew will do whatever it takes to make it to that forum. Certainly have a lot more data collected over the past year (since last ASCO) that would be worthy of discussing. Time will tell, but odds are good, I think.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

BC Mosaic App Store Unlocks New Tools for Researchers

Updated Category News Views 2

Unleashing Innovation Through Specialized Apps Oh boy, it's about time someone shook things up in the research game. BC Platforms has rolled out the BC Mosaic App Store, a move that's got research types buzzing from Zurich to... well, anywhere healthcare pokes its head. These guys aren't just throwing out some generic, run-of-the-mill tools. No sir, they've created a...

Continue Reading
Broadridge Expands Tokenization with G7 Securities

Updated Category News Views 9

Broadridge Takes a Big Step with G7 Integration Broadridge Financial Solutions is pulling no punches with its latest move—integrating G7 securities into its Distributed Ledger Repo (DLR) network. This isn't your average fintech maneuver; it's a heavyweight shift intended to redefine the way global financing and collateral markets work. Tokenized Repo: More Than Just a...

Continue Reading
Skanska's $57M Deal to Transform Del Mar Traffic

Updated Category News Views 5

A Roadway Overhaul in Del Mar A cool $57 million. That’s the ticket Skanska bought to scoop up the El Camino Real project in Del Mar, California. Think of it as a road facelift, a necessary one—it includes bulking up the corridor to four lanes and swapping in a spanking new San Dieguito River Bridge, taking the place of an old rascal that's been around for 84 years....

Continue Reading
Fibocom's RU311: Navigating 5G's Mid-Tier Maze

Updated Category News Views 4

Cracking Open the RU311 Phenomenon Technology must evolve with purpose. This time around, Fibocom's RU311 module series steps up to the plate, delivering a tailored solution in the 5G landscape for the mid-tier IoT devices that need more than just speed. Beyond Raw Bandwidth: What Really Matters Plenty of folks out there still chase the elusive thrill of higher speeds as...

Continue Reading
Royal Mint Ventures Into the Final Frontier with Star Trek Coins

Updated Category News Views 1

A Cosmic Coin Collection for the Ages The Royal Mint has stepped boldly into a realm where no coin has gone before—celebrating six decades of Star Trek with two new collectable 50p coins. For Star Trek fans who’ve followed the Enterprise to the furthest reaches of the galaxy, these coins aren’t just chump change—they’re keepsakes that capture a piece of sci-fi...

Continue Reading
stackArmor Secures FedRAMP High: A Strategic Milestone

Updated Category News Views 2

stackArmor: Carving a Niche in Federal Cybersecurity Hey, not every day you wake up to find a company carving its niche in federal cybersecurity quite the way stackArmor is doing. They've recently got their hands on that elusive FedRAMP High authorization for The Armory. What's this mean in English? Well, for starters, these guys are showing they're serious about...

Continue Reading
BOC Group's Challenger Role Eye-Opener in Gartner Quadrant

Updated Category News Views 6

Cracking the Challenger Code: BOC Group's Debut Ever heard of BOC Group? If you haven’t, it’s time to pay attention. This Dublin-based outfit just muscled its way into the Challenger Quadrant of the 2026 Gartner Magic Quadrant for Digital Twin of an Organization Platforms. Not bad for its first trip to the dance. When a company crashes the scene like this, eyebrows...

Continue Reading
COFE Tech's $178M Pre-IPO Boost: Bold Move in MENA

Updated Category News Views 1

COFE Tech's Pre-IPO Raise: Scoring Big Dollars Today I'm reading this deal 'bout COFE Tech, and let me tell ya, there's more to chew over than a bowl of oatmeal. They just wrapped up a pre-IPO round at a hefty $178 million valuation. This wasn't just any ol' investment — we're talking about Wa'ed Ventures, the venture arm of Aramco, along with some heavy-hitter partners...

Continue Reading
Danielle D. Pollard Releases Game-Changing Exec Book

Updated Category News Views 0

Revolutionizing Communication Dynamics In a world where every word is scrutinized, Danielle D. Pollard's new book, Act Like a Lady, Speak Like a Wolf, arrives like a jolt of caffeine on a sleepy morning. With decades of engineering know-how and corporate grit, Pollard serves up a no-frills strategy to conquer the communication game, especially designed for women fighting...

Continue Reading
Veteran Suicide Prevention: The Urgency Behind CVN's Push

Updated Category News Views 0

Veteran suicide is a crisis staring us square in the face, with rates 60% higher than the general population. It's a grim reminder that the mental toll on those who've served is a deep chasm hard to bridge. Cohen Veterans Network (CVN) is stepping up to the plate with a new campaign dubbed 'Ask Anyway: Conversations to Save a Life'. This isn't just any awareness...

Continue Reading

Top 5 Most Recently Viewed Articles

Dillard's, Inc. Financial Overview: Q3 and Yearly Insights

Updated Category News Views 332

Insights into Dillard's, Inc. Financial Performance Dillard's, Inc. (NYSE: DDS) has recently disclosed its operating results for the 13 and 39 weeks ending on a notable date. The retail landscape has faced challenges, which are reflected in the company’s sales data and overall performance metrics. CEO's Statement on Q3 Results William T. Dillard, II, the Chief Executive...

Continue Reading
Transforming Cannabis Consumption: The Rise of Vapes and Pre-Rolls

Updated Category News Views 84

The Evolution of Cannabis Consumption in Canada Recent equity research provides fascinating insights into the Canadian cannabis market. Analysts have observed a shift in consumer preferences, particularly noting a slowdown in the growth of recreational cannabis sales. This trend prompts questions about how consumption habits are evolving among Canadians. Current Market...

Continue Reading
Celebrating Music and Wine: The 10th Annual Festival Begins

Updated Category News Views 287

Celebrating a Milestone in Music and Wine At the heart of the Willamette Valley, the Appassionata Estate is set to host a special celebration as the 10th annual Willamette Valley Chamber Music Festival opens its doors once again. This festival is not just an event; it's a fusion of music, wine, and heartfelt community connections that folks have enjoyed for a decade. As...

Continue Reading
Transforming Data Control for Users with dFusion and VANA

Updated Category News Views 285

Empowering Users with Decentralized Data Ownership dFusion AI, in conjunction with VANA, has introduced a groundbreaking initiative known as the Private Social Lens Data Liquidity Pool (DLP). This innovative framework is set to revolutionize the way conversational data, particularly Telegram messages, is collected, validated, and monetized. This effort signifies a major...

Continue Reading
Guselkumab's Innovative Approval Revolutionizes Treatment Options

Updated Category News Views 199

Understanding the Advancement of Guselkumab Guselkumab is set to redefine treatment protocols for adults dealing with ulcerative colitis (UC) and Crohn's disease (CD), providing patients and healthcare providers with the convenience and flexibility of self-administration from the initiation of therapy. The introduction of TREMFYA® (guselkumab) allows for a fully...

Continue Reading